Dovepress Nanoinformatics: a new area of research in nanomedicine Appendix This appendix presents a very large table listing the large number of initiatives and databases spanning the collecting, gathering, curating, and providing of nano-related information for professionals and other nanotechnology users. Table A1 Summary of current nanoinformatics initiatives and projects Geographical area Start year USA Name/acronym Description Initiatives and scientific networks Nano Science and Technology It integrates nano and other Institute (NSTI) technologies through education, conventions, business publishing, and research services NanoBioTechnology Center Experts on nanobiotechnology: biomolecular devices, cellular microdynamics, cell–surface interactions, cell biology, etc National Nanotechnology Central point of communication, Initiative (NNI) cooperation, and collaboration for all US federal agencies engaged in nanotechnology research Global Nanotechnology Platform for addressing shared Network global challenges through nanoscale science, engineering, development, and education International Council on Portal for information about the Nanotechnology (ICON) environmental, health, and safety aspects of nanotechnology National Cancer Institute (NCI) Committed to build a community Alliance for nanotechnology of researchers dedicated to using in Cancer nanotechnology to advance the fight against cancer Alliance for NanoHealth Promotes nano-based approaches, nano-resources, and tools to battle against cancer, heart diseases, or diabetes European Technology Platform Led by industry together with the on Nanomedicine European Commission (EC) for the application of nanotechnology in health care Nanoforum European Nanotechnology Gateway Nanomedicine Roadmap Initiative Nanotechnology Characterization Laboratory Nanotechnologies Industries Association Project on Emerging Nanotechnologies Nanomachinery of the cell to control and manipulate molecules and supramolecular assemblies in living cells A NCI-supported lab to perform and standardize nanomaterials intended for cancer therapeutics and diagnostics It represents the industries’ views, interfaces with governments, consultation on regulation, standards, media and public Designed to minimize potential risks to health and environment, identifying gaps in knowledge and regulatory processes International Journal of Nanomedicine 2012:7 Institution NSTI National Science Foundation (NSF) USA 25 US governmental agencies USA Diverse nanotechnology stakeholders from industry, academia, and government Rice University NCI, US National Institutes of Health (NIH) Texas Medical Center (Houston, TX) EC Former Fifth RTD Framework Programme, now an European Economic Interest Group US NIH NCI, US NIH Group of companies from a variety of industry sectors Pew Charitable Trusts, woodrow wilson International Center for Scholars International USA USA USA Europe Europe USA USA International USA 1997 2000 2000 2001 2004 2004 2005 2005 2005 2005 2005 2005 2005 (Continued) submit your manuscript | www.dovepress.com Dovepress 3885